Month: June 2020

When Victoria was diagnosed with fibromyalgia, her future looked bleak. But the agonising condition taught her to fight, to change, and to forge a successful new life So, picture me, just 25 years old, sitting in a consultant’s office, feeling vulnerable and scared, being given the damning diagnosis: “You have fibromyalgia… it will get worse…
0 Comments
Pharmaceutical company AstraZeneca is aiming to produce 2 billion doses of a coronavirus vaccine, including 400 million for the U.S. and U.K. and 1 billion for those in low- and middle-income countries.  It plans to start distributing the vaccine to the U.S. and U.K. in September or October, with the balance of deliveries likely to
0 Comments
The number of reported cases of congenital syphilis has risen almost fourfold since 2013 — a result of multiple missed opportunities for prevention during pregnancy, researchers say. From 2013 to 2018, reported cases of congenital syphilis increased from 362 to 1306, with 94 stillbirths or early infant deaths occurring during 2018 alone. “This is the
0 Comments
31 May – Shielding advice updated in England, Wales and Northern Ireland 29 May – UK nations begin to ease lockdown restrictions 28 May – UK nations launch test and trace systems  27 April – NHS campaign urges people to get help if they need it 21 April – Urgent cancer referrals fall across the
0 Comments
Print this page NEW YORK–(BUSINESS WIRE) June 03, 2020 — Pfizer Inc. (NYSE: PFE) announced today that JAMA Dermatology has published complete results from the second Phase 3 monotherapy pivotal study (JADE MONO-2) of abrocitinib, an investigational oral once-daily Janus kinase 1 (JAK1) inhibitor, in patients aged 12 and older with moderate to severe atopic
0 Comments
Studies reveal that as the lockdown continues, loneliness will start to affect teenagers more and more, leading to long-term negative impacts. Lockdown Loneliness And Its Long-Term Impact On Teenagers As the pandemic continues, it’s becoming clearer and clearer that the coronavirus isn’t only affecting our physical health, but our mental and emotional well-being as well,
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Hydroxychloroquine (HCQ) does not reduce the risk for infection in people exposed to patients with confirmed COVID-19, according to data from a randomized, double-blind, placebo-controlled prevention trial. The trial enrolled 821 asymptomatic participants from multiple sites in the United States and
0 Comments
Reviewed by Emily Henderson, B.Sc.Jun 3 2020 Following positive preliminary data, Octapharma USA is extending funding for an investigator-initiated study (IIS) focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing hypoxia and who are at the highest risk of requiring mechanical ventilation. The research is led by infectious
0 Comments
June 1, 2020 Print this page Audience: Consumer, Health Professional, Pharmacy June 1, 2020 — FDA is alerting patients, caregivers and health care professionals to immediately inspect certain lots of Amneal and Impax epinephrine auto-injector 0.3 mg to ensure the yellow “stop collar” in the device is present. In letters to health care professionals and
0 Comments
We know that it has been harder for people to exercise over these last several weeks. Christina Lombardi, DPT PT has put together easy exercises to get you moving at home! Each Wednesday for the next several weeks we will share these exercises with you. Each exercise includes descriptive information and a video to demonstrate
0 Comments
Are you a non-black person unsure of how best to support the anti-racist movement? Here are some ways you can help There has been an outpouring of support for black lives in the last week and, in this moment of crisis, it’s an amazing and important thing that we are fired up and ready to
0 Comments
Executive Director of the World Health Organization’s (WHO) emergencies program Mike Ryan speaks at a news conference on the novel coronavirus (2019-nCoV) in Geneva, Switzerland February 6, 2020. Denis Balibouse | Reuters The coronavirus has not mutated in any way that would meaningfully change how quickly it spreads or how severely it can harm humans,
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Moderately ill COVID-19 patients benefit from a 5-day course of the investigational drug remdesivir, Gilead Sciences announced on Monday. The topline results from the company’s randomized phase 3 SIMPLE trial are the first to show that the drug improves outcomes among
0 Comments
As the Covid-19 pandemic continues and guidance changes, it’s important for us to stay aware of how best to protect ourselves. This, inevitably, leads many of us turning to the news as a source of information. The problem is, the information being published is feeling overwhelming for many. Many of us have experienced anxiety rising
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. June 2, 2020 — Ana Anselmo of Miami is no stranger to avoiding busy and public spaces for health reasons. She and her husband have regularly steered clear of both because their daughter Savannah was born with a rare disease that
0 Comments
Mayo Clinic’s Christopher Sletten, Ph.D., ABPP discussing Central Sensitization Syndrome, which is the prevailing theory of the cause of chronic pain & other chronic symptoms. A patient and/or provider understanding of this process can lead to seeking appropriate treatments including the Pain Rehab Center (PRC) at Mayo Clinic’s Florida campus. Learn more about the PRC
0 Comments
http://armandoh.org/ https://www.facebook.com/ArmandoHasudungan Support me: http://www.patreon.com/armando Instagram: http://instagram.com/armandohasudungan Twitter: Tweets by armando71021105 Aracidonic Acid: http://www.youtube.com/watch?v=VSc9U8JaWYg Osteoporosis: http://www.youtube.com/watch?v=2cz2rkBy2rg
0 Comments
Reviewed by Emily Henderson, B.Sc.Jun 2 2020 Seattle Children’s Research Institute, one of the top pediatric research institutions in the world, and global biotechnology leader CSL Behring announced a strategic alliance to develop stem cell gene therapies for primary immunodeficiency diseases. Initially, the alliance will focus on the development of treatment options for patients with
0 Comments
FDA Approves Zilxi (minocycline) Topical Foam for the Treatment of Rosacea Print this page BRIDGEWATER, N.J., May 29, 2020 (GLOBE NEWSWIRE) — Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the “Company”), a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announced that the U.S. Food and
0 Comments